Kerstin Landin-Wilhelmsen

Kerstin Landin-Wilhelmsen

Auto-generated profile, based on publicly available information

Kerstin Landin-Wilhelmsen

Sahlgrenska University Hospital at Sahlgrenska Academy, University of Gothenburg

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1990 in Metabolism
Verified
Journal Article
Closed access
KLKerstin Landin
Kerstin Landin
LSLennart Stigendal
Lennart Stigendal
EEElsa Eriksson
Elsa Eriksson
MKMarcin Krotkiewski
Marcin Krotkiewski
BRBo Risberg
Bo Risberg
USUlf Smith
Ulf Smith

1 April 1990 in Journal of Internal Medicine
Verified
Journal Article
Closed access
PDF file
KLK. Landin
K. Landin
LTL. Tengborn
L. Tengborn
USU. Smith
U. Smith

1 August 1997 in Cancer
Verified
Journal Article
Closed access
PDF file
HRHaakon Ragde
Haakon Ragde
JBJohn C. Blasko
John C. Blasko
PGPeter D. Grimm
Peter D. Grimm
GKGerald M. Kenny
Gerald M. Kenny
JSJohn E. Sylvester
John E. Sylvester
WCWilliam Cavanagh
William Cavanagh

1 December 2011 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
JSJohanna Schmidt
Johanna Schmidt
KLKerstin Landin-Wilhelmsen
Kerstin Landin-Wilhelmsen
MBMats Brännström
Mats Brännström
EDEva Dahlgren
Eva Dahlgren
Polycystic ovary syndrome (PCOS) is associated with the metabolic syndrome and, consequently, with a potentially increased risk of cardiovascular disease (CVD) and related mortality later in life. Studies regarding CVD and mortality in PCOS women well into the postmenopausal age are lacking. Our objective was to examine whether postmenopausal PCOS women differ from controls regarding cardiovascular risk factors, myocardial infarction (MI), stroke and mortality. We conducted, at a university hospital, a prospective study of 35 PCOS women (61-79 yr) and 120 age-matched controls. The study was performed 21 yr after the initial study. Twenty-five PCOS women (Rotterdam criteria) and 68 controls participated in all examinations. Data on morbidity were based on 32 of 34 PCOS women and on 95 of 119 controls. INTERVENTIONS included reexamination, interviews, and data from the National Board of Health and Welfare and from the Hospital Discharge Registry. Blood pressure, glucose, insulin, triglycerides, total cholesterol, high- and low-density lipoprotein, apolipoprotein A1 and B, fibrinogen, and plasminogen activator inhibitor antigen were studied. Incidences of MI, stroke, hypertension, diabetes, cancer, cause of death, and age at death were recorded. PCOS women had a higher prevalence of hypertension (P = 0.008) and higher triglyceride levels (P = 0.012) than controls. MI, stroke, diabetes, cancer, and mortality prevalence was similar in the two cohorts with similar body mass index. The well-described cardiovascular/metabolic risk profile in pre- and perimenopausal PCOS women does not entail an evident increase in cardiovascular events during the postmenopausal period.

1 September 2008 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
MMMattias Månsson
Mattias Månsson
JHJan Holte
Jan Holte
KLKerstin Landin-Wilhelmsen
Kerstin Landin-Wilhelmsen
EDEva Dahlgren
Eva Dahlgren
AJAnette Johansson
Anette Johansson
MLMikael Landén
Mikael Landén

1 September 1995 in Metabolism
Verified
Journal Article
Closed access
JJJan-Ove Johansson
Jan-Ove Johansson
JFJesper Fowelin
Jesper Fowelin
KLKerstin Landin
Kerstin Landin
ILIbe Lager
Ibe Lager
BBBengt-Åke Bengtsson
Bengt-Åke Bengtsson